Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Summary of progress

From: Visualizing epileptogenic regions using the chemical exchange saturation transfer method in a patient with drug-resistant focal epilepsy: a case report

Preoperative course

2017: onset of seizure symptoms with behavioral abnormalities during sleep

2018: start of LEV

2019: seizures suppressed by adding CZP

2021: the patient was referred to our hospital because his seizures were not controlled despite the addition of CZP, LCM, and PER

Test results

Electroencephalography: spiny waves were observed in the bilateral antero-medial temporal regions

It was difficult to identify the starting point from EEG findings during seizure

Head MRI: no obvious abnormal findings. No hippocampal sclerosis or atrophy

FDG-PET: hypoglycemia in the left anterolateral temporal region

Surgery

Intracranial electrode implantation: subdural electrodes were implanted in the lateral and medial left temporal lobe, and in the frontal lobe. Intracranial electrodes were placed in the lateral and medial left temporal lobe, and frontal lobe.

Intracranial EEG during seizure showed repeated spikes in the temporal pole followed by propagation to the lateral temporal lobe

Focal resection: resection of the left lateral temporal lobe, including the temporal pole, was performed. Intraoperative hippocampal wave recordings showed a low frequency of spikes, so the hippocampus was preserved

Post-surgery

Four months postoperatively, FAS recurred. One year after surgery, FIAS disappeared

  1. LEV, levetiracetam; LCM, lacosamide; PER, perampanel; CZP, cronazepam; EEG, electroencephalography; MRI, magnetic resonance imaging; FDG-PET, fluorodeoxyglucose-positron emission tomography; FAS, focal aware seizures; FIAS, focal impaired awareness seizures